FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1535-1548 April 8, 2004 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The rate of success in the treatment of acute lymphoblastic leukemia (ALL) has increased steadily since the 1960s. The five-year event-free survival rate is nearly 80 percent for children with ALL and approximately 40 percent for adults (Table 1).^{1,2,3,4,5,6,7,8,9} If we include cases of relapsed ALL that respond well to so-called remission retrieval therapy, the rates of cure (defined by the absence of evidence of disease for at least 10 years) with the use of modern treatments are about 80 percent for children and 40 percent for adults.^10,11 Attempts to boost cure rates further with the use of . . . [Full Text of this Article]

Molecular Genetic Alterations

Primary Abnormalities

Chimeric Transcription Factors

            The TEL-AML1 Fusion Gene

            Translocations Involving the MLL Gene

            Other HOX Genes and HOX Cofactors

Cooperative Mutations

            The FLT-3 Receptor

            The Retinoblastoma Pathways

            TP53

Prognostic Factors

Sensitivity to Chemotherapy

Influence of Age

Gene-Expression Profiling

Molecular Epidemiology

In Utero Development of All

Age at Presentation

Genetic Polymorphisms

            Detoxifying Enzymes

            Folate-Metabolizing Enzymes

Pharmacogenetics

Future Directions

Source Information

From the Departments of Hematology/Oncology (C.-H.P.), Pharmaceutical Sciences (M.V.R.), and Pathology (C.-H.P., J.R.D.), St. Jude Children's Research Hospital; and the Colleges of Medicine (C.-H.P., M.V.R., J.R.D.) and Pharmacy (M.V.R.), University of Tennessee Health Science Center — both in Memphis.

Address reprint requests to Dr. Pui at St. Jude Children's Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105, or at ching-hon.pui@stjude.org.

Related Letters:

Magnetic Fields and Leukemia
Hocking B., Pui C.-H., Relling M. V., Downing J. R.
Extract | Full Text | PDF  
N Engl J Med 2004; 351:102, Jul 1, 2004. Correspondence

This article has been cited by other articles:

• Ongaro, A., De Mattei, M., Della Porta, M. G., Rigolin, G., Ambrosio, C., Di Raimondo, F., Pellati, A., Masieri, F. F., Caruso, A., Catozzi, L., Gemmati, D. (2009). Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival. haematol 94: 1391-1398 [Abstract] [Full Text]  
• Linger, R. M. A., DeRyckere, D., Brandao, L., Sawczyn, K. K., Jacobsen, K. M., Liang, X., Keating, A. K., Graham, D. K. (2009). Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia. Blood 114: 2678-2687 [Abstract] [Full Text]  
• Tosello, V., Mansour, M. R., Barnes, K., Paganin, M., Sulis, M. L., Jenkinson, S., Allen, C. G., Gale, R. E., Linch, D. C., Palomero, T., Real, P., Murty, V., Yao, X., Richards, S. M., Goldstone, A., Rowe, J., Basso, G., Wiernik, P. H., Paietta, E., Pieters, R., Horstmann, M., Meijerink, J. P. P., Ferrando, A. A. (2009). WT1 mutations in T-ALL. Blood 114: 1038-1045 [Abstract] [Full Text]  
• Asnafi, V., Buzyn, A., Le Noir, S., Baleydier, F., Simon, A., Beldjord, K., Reman, O., Witz, F., Fagot, T., Tavernier, E., Turlure, P., Leguay, T., Huguet, F., Vernant, J.-P., Daniel, F., Bene, M.-C., Ifrah, N., Thomas, X., Dombret, H., Macintyre, E. (2009). NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood 113: 3918-3924 [Abstract] [Full Text]  
• Grinberg-Rashi, H., Ofek, E., Perelman, M., Skarda, J., Yaron, P., Hajduch, M., Jacob-Hirsch, J., Amariglio, N., Krupsky, M., Simansky, D. A., Ram, Z., Pfeffer, R., Galernter, I., Steinberg, D. M., Ben-Dov, I., Rechavi, G., Izraeli, S. (2009). The Expression of Three Genes in Primary Non-Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain. Clin. Cancer Res. 15: 1755-1761 [Abstract] [Full Text]  
• Yang, H., Kadia, T., Xiao, L., Bueso-Ramos, C. E., Hoshino, K., Thomas, D. A., O'Brien, S., Jabbour, E., Pierce, S., Rosner, G. L., Kantarjian, H. M., Garcia-Manero, G. (2009). Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia. Blood 113: 1892-1898 [Abstract] [Full Text]  
• Chiaretti, S., Foa, R. (2009). T-cell acute lymphoblastic leukemia. haematol 94: 160-162 [Full Text]  
• Attiyeh, E. F., Diskin, S. J., Attiyeh, M. A., Mosse, Y. P., Hou, C., Jackson, E. M., Kim, C., Glessner, J., Hakonarson, H., Biegel, J. A., Maris, J. M. (2009). Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy. Genome Res 19: 276-283 [Abstract] [Full Text]  
• O'Brien, S. M., Thomas, D. A., Faderl, S. (2009). A La Carte Therapy of Specific Acute Lymphocytic Leukemia Subsets. Am Soc Clin Oncol Ed Book 2009: 365-370 [Abstract] [Full Text]  
• Chokkalingam, A. P., Buffler, P. A. (2008). Genetic susceptibility to childhood leukaemia. Radiat Prot Dosimetry 132: 119-129 [Abstract] [Full Text]  
• Inthal, A., Krapf, G., Beck, D., Joas, R., Kauer, M. O., Orel, L., Fuka, G., Mann, G., Panzer-Grumayer, E. R. (2008). Role of the Erythropoietin Receptor in ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia. Clin. Cancer Res. 14: 7196-7204 [Abstract] [Full Text]  
• Teuffel, O., Stanulla, M., Cario, G., Ludwig, W. D., Rottgers, S., Schafer, B. W., Zimmermann, M., Schrappe, M., Niggli, F. K. (2008). Anemia and survival in childhood acute lymphoblastic leukemia. haematol 93: 1652-1657 [Abstract] [Full Text]  
• Kawamata, N., Ogawa, S., Zimmermann, M., Niebuhr, B., Stocking, C., Sanada, M., Hemminki, K., Yamatomo, G., Nannya, Y., Koehler, R., Flohr, T., Miller, C. W., Harbott, J., Ludwig, W.-D., Stanulla, M., Schrappe, M., Bartram, C. R., Koeffler, H. P. (2008). Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Proc. Natl. Acad. Sci. USA 105: 11921-11926 [Abstract] [Full Text]  
• Tucci, F., Arico, M. (2008). Treatment of pediatric acute lymphoblastic leukemia. haematol 93: 1124-1128 [Full Text]  
• Manabe, A., Ohara, A., Hasegawa, D., Koh, K., Saito, T., Kiyokawa, N., Kikuchi, A., Takahashi, H., Ikuta, K., Hayashi, Y., Hanada, R., Tsuchida, M. (2008). Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15. haematol 93: 1155-1160 [Abstract] [Full Text]  
• Deem, A., Barker, K., VanHulle, K., Downing, B., Vayl, A., Malkova, A. (2008). Defective Break-Induced Replication Leads to Half-Crossovers in Saccharomyces cerevisiae. Genetics 179: 1845-1860 [Abstract] [Full Text]  
• Wiemels, J. (2008). Chromosomal Translocations in Childhood Leukemia: Natural History, Mechanisms, and Epidemiology. J Natl Cancer Inst Monogr 2008: 87-90 [Abstract] [Full Text]  
• Jeong, E. G., Kim, M. S., Nam, H. K., Min, C. K., Lee, S., Chung, Y. J., Yoo, N. J., Lee, S. H. (2008). Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers. Clin. Cancer Res. 14: 3716-3721 [Abstract] [Full Text]  
• Rubnitz, J. E., Wichlan, D., Devidas, M., Shuster, J., Linda, S. B., Kurtzberg, J., Bell, B., Hunger, S. P., Chauvenet, A., Pui, C.-H., Camitta, B., Pullen, J. (2008). Prospective Analysis of TEL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. JCO 26: 2186-2191 [Abstract] [Full Text]  
• Van Vlierberghe, P., van Grotel, M., Tchinda, J., Lee, C., Beverloo, H. B., van der Spek, P. J., Stubbs, A., Cools, J., Nagata, K., Fornerod, M., Buijs-Gladdines, J., Horstmann, M., van Wering, E. R., Soulier, J., Pieters, R., Meijerink, J. P. P. (2008). The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood 111: 4668-4680 [Abstract] [Full Text]  
• Balgobind, B. V., Van Vlierberghe, P., van den Ouweland, A. M. W., Beverloo, H. B., Terlouw-Kromosoeto, J. N. R., van Wering, E. R., Reinhardt, D., Horstmann, M., Kaspers, G. J. L., Pieters, R., Zwaan, C. M., Van den Heuvel-Eibrink, M. M., Meijerink, J. P. P. (2008). Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood 111: 4322-4328 [Abstract] [Full Text]  
• De Keersmaecker, K., Lahortiga, I., Mentens, N., Folens, C., Van Neste, L., Bekaert, S., Vandenberghe, P., Odero, M. D., Marynen, P., Cools, J. (2008). In vitro validation of {gamma}-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. haematol 93: 533-542 [Abstract] [Full Text]  
• Oudot, C., Auclerc, M.-F., Levy, V., Porcher, R., Piguet, C., Perel, Y., Gandemer, V., Debre, M., Vermylen, C., Pautard, B., Berger, C., Schmitt, C., Leblanc, T., Cayuela, J.-M., Socie, G., Michel, G., Leverger, G., Baruchel, A. (2008). Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study. JCO 26: 1496-1503 [Abstract] [Full Text]  
• Pullarkat, V., Slovak, M. L., Kopecky, K. J., Forman, S. J., Appelbaum, F. R. (2008). Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Blood 111: 2563-2572 [Abstract] [Full Text]  
• Ong, V., Liem, N. L. M., Schmid, M. A., Verrills, N. M., Papa, R. A., Marshall, G. M., MacKenzie, K. L., Kavallaris, M., Lock, R. B. (2008). A Role for Altered Microtubule Polymer Levels in Vincristine Resistance of Childhood Acute Lymphoblastic Leukemia Xenografts. J. Pharmacol. Exp. Ther. 324: 434-442 [Abstract] [Full Text]  
• Kawamata, N., Ogawa, S., Zimmermann, M., Kato, M., Sanada, M., Hemminki, K., Yamatomo, G., Nannya, Y., Koehler, R., Flohr, T., Miller, C. W., Harbott, J., Ludwig, W.-D., Stanulla, M., Schrappe, M., Bartram, C. R., Koeffler, H. P. (2008). Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 111: 776-784 [Abstract] [Full Text]  
• Mi, S., Lu, J., Sun, M., Li, Z., Zhang, H., Neilly, M. B., Wang, Y., Qian, Z., Jin, J., Zhang, Y., Bohlander, S. K., Le Beau, M. M., Larson, R. A., Golub, T. R., Rowley, J. D., Chen, J. (2007). MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 104: 19971-19976 [Abstract] [Full Text]  
• Fischer, S., Mann, G., Konrad, M., Metzler, M., Ebetsberger, G., Jones, N., Nadel, B., Bodamer, O., Haas, O. A., Schmitt, K., Panzer-Grumayer, E. R. (2007). Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin. Blood 110: 3036-3038 [Abstract] [Full Text]  
• Clappier, E., Cuccuini, W., Kalota, A., Crinquette, A., Cayuela, J.-M., Dik, W. A., Langerak, A. W., Montpellier, B., Nadel, B., Walrafen, P., Delattre, O., Aurias, A., Leblanc, T., Dombret, H., Gewirtz, A. M., Baruchel, A., Sigaux, F., Soulier, J. (2007). The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 110: 1251-1261 [Abstract] [Full Text]  
• Choi, S., Henderson, M. J., Kwan, E., Beesley, A. H., Sutton, R., Bahar, A. Y., Giles, J., Venn, N. C., Pozza, L. D., Baker, D. L., Marshall, G. M., Kees, U. R., Haber, M., Norris, M. D. (2007). Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood 110: 632-639 [Abstract] [Full Text]  
• Maule, M., Scelo, G., Pastore, G., Brennan, P., Hemminki, K., Tracey, E., Sankila, R., Weiderpass, E., Olsen, J. H., McBride, M. L., Brewster, D. H., Pompe-Kirn, V., Kliewer, E. V., Chia, K. S., Tonita, J. M., Martos, C., Jonasson, J. G., Merletti, F., Boffetta, P. (2007). Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma: An International Study. JNCI J Natl Cancer Inst 99: 790-800 [Abstract] [Full Text]  
• Kishi, S., Cheng, C., French, D., Pei, D., Das, S., Cook, E. H., Hijiya, N., Rizzari, C., Rosner, G. L., Frudakis, T., Pui, C.-H., Evans, W. E., Relling, M. V. (2007). Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood 109: 4151-4157 [Abstract] [Full Text]  
• Bachmann, P. S., Gorman, R., Papa, R. A., Bardell, J. E., Ford, J., Kees, U. R., Marshall, G. M., Lock, R. B. (2007). Divergent Mechanisms of Glucocorticoid Resistance in Experimental Models of Pediatric Acute Lymphoblastic Leukemia. Cancer Res. 67: 4482-4490 [Abstract] [Full Text]  
• Diakos, C., Krapf, G., Gerner, C., Inthal, A., Lemberger, C., Ban, J., Dohnal, A. M., Panzer-Grumayer, E. R. (2007). RNAi-mediated silencing of TEL/AML1 reveals a heat-shock protein- and survivin-dependent mechanism for survival. Blood 109: 2607-2610 [Abstract] [Full Text]  
• Miething, C., Grundler, R., Mugler, C., Brero, S., Hoepfl, J., Geigl, J., Speicher, M. R., Ottmann, O., Peschel, C., Duyster, J. (2007). Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment. Proc. Natl. Acad. Sci. USA 104: 4594-4599 [Abstract] [Full Text]  
• Pui, C.-H. (2007). Livin: a proapoptotic factor in ALL?. Blood 109: 394-395 [Full Text]  
• Choi, J., Hwang, Y. K., Sung, K. W., Lee, S. H., Yoo, K. H., Jung, H. L., Koo, H. H., Kim, H.-J., Kang, H. J., Shin, H. Y., Ahn, H. S. (2007). Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 109: 471-477 [Abstract] [Full Text]  
• Schmidt, S., Irving, J. A. E., Minto, L., Matheson, E., Nicholson, L., Ploner, A., Parson, W., Kofler, A., Amort, M., Erdel, M., Hall, A., Kofler, R. (2006). Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor. FASEB J. 20: 2600-2602 [Abstract] [Full Text]  
• Mostert, S., Sitaresmi, M. N., Gundy, C. M., Sutaryo, , Veerman, A. J. P. (2006). Influence of Socioeconomic Status on Childhood Acute Lymphoblastic Leukemia Treatment in Indonesia. Pediatrics 118: e1600-e1606 [Abstract] [Full Text]  
• Van Vlierberghe, P., van Grotel, M., Beverloo, H. B., Lee, C., Helgason, T., Buijs-Gladdines, J., Passier, M., van Wering, E. R., Veerman, A. J. P., Kamps, W. A., Meijerink, J. P. P., Pieters, R. (2006). The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 108: 3520-3529 [Abstract] [Full Text]  
• Sabaawy, H. E., Azuma, M., Embree, L. J., Tsai, H.-J., Starost, M. F., Hickstein, D. D. (2006). TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 103: 15166-15171 [Abstract] [Full Text]  
• Verrills, N. M., Po'uha, S. T., Liu, M. L. M., Liaw, T. Y. E., Larsen, M. R., Ivery, M. T., Marshall, G. M., Gunning, P. W., Kavallaris, M. (2006). Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.. JNCI J Natl Cancer Inst 98: 1363-1374 [Abstract] [Full Text]  
• Pereira, T. V., Rudnicki, M., Pereira, A. C., Pombo-de-Oliveira, M. S., Franco, R. F. (2006). 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and Acute Lymphoblastic Leukemia Risk: A Meta-analysis.. Cancer Epidemiol. Biomarkers Prev. 15: 1956-1963 [Abstract] [Full Text]  
• Shalapour, S., Zelmer, A., Pfau, M., Moderegger, E., Costa-Blechschmidt, C., van Landeghem, F. K.H., Taube, T., Fichtner, I., Buhrer, C., Henze, G., Seeger, K., Wellmann, S. (2006). The Thalidomide Analogue, CC-4047, Induces Apoptosis Signaling and Growth Arrest in Childhood Acute Lymphoblastic Leukemia Cells In vitro and In vivo.. Clin. Cancer Res. 12: 5526-5532 [Abstract] [Full Text]  
• Breit, S., Stanulla, M., Flohr, T., Schrappe, M., Ludwig, W.-D., Tolle, G., Happich, M., Muckenthaler, M. U., Kulozik, A. E. (2006). Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 108: 1151-1157 [Abstract] [Full Text]  
• Flotho, C., Coustan-Smith, E., Pei, D., Iwamoto, S., Song, G., Cheng, C., Pui, C.-H., Downing, J. R., Campana, D. (2006). Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood 108: 1050-1057 [Abstract] [Full Text]  
• Coustan-Smith, E., Ribeiro, R. C., Stow, P., Zhou, Y., Pui, C.-H., Rivera, G. K., Pedrosa, F., Campana, D. (2006). A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Blood 108: 97-102 [Abstract] [Full Text]  
• Loh, M. L., Goldwasser, M. A., Silverman, L. B., Poon, W.-M., Vattikuti, S., Cardoso, A., Neuberg, D. S., Shannon, K. M., Sallan, S. E., Gilliland, D. G. (2006). Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01. Blood 107: 4508-4513 [Abstract] [Full Text]  
• Schmidt, S., Rainer, J., Riml, S., Ploner, C., Jesacher, S., Achmuller, C., Presul, E., Skvortsov, S., Crazzolara, R., Fiegl, M., Raivio, T., Janne, O. A., Geley, S., Meister, B., Kofler, R. (2006). Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 107: 2061-2069 [Abstract] [Full Text]  
• Chen, Y.-X., Yan, J., Keeshan, K., Tubbs, A. T., Wang, H., Silva, A., Brown, E. J., Hess, J. L., Pear, W. S., Hua, X. (2006). The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc. Natl. Acad. Sci. USA 103: 1018-1023 [Abstract] [Full Text]  
• Holleman, A., den Boer, M. L., de Menezes, R. X., Cheok, M. H., Cheng, C., Kazemier, K. M., Janka-Schaub, G. E., Gobel, U., Graubner, U. B., Evans, W. E., Pieters, R. (2006). The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 107: 769-776 [Abstract] [Full Text]  
• Pui, C.-H., Evans, W. E. (2006). Treatment of Acute Lymphoblastic Leukemia. NEJM 354: 166-178 [Full Text]  
• Downing, J. R., Mullighan, C. G. (2006). Tumor-Specific Genetic Lesions and Their Influence on Therapy in Pediatric Acute Lymphoblastic Leukemia. ASH Education Book 2006: 118-122 [Abstract] [Full Text]  
• Gleissner, B., Goekbuget, N., Rieder, H., Arnold, R., Schwartz, S., Diedrich, H., Schoch, C., Heinze, B., Fonatsch, C., Bartram, C. R., Hoelzer, D., Thiel, E., for the GMALL Study Group, (2005). CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL). Blood 106: 4054-4056 [Abstract] [Full Text]  
• Wang, Y., Moorhead, M., Karlin-Neumann, G., Falkowski, M., Chen, C., Siddiqui, F., Davis, R. W., Willis, T. D., Faham, M. (2005). Allele quantification using molecular inversion probes (MIP). Nucleic Acids Res 33: e183-e183 [Abstract] [Full Text]  
• Pui, C.-H., Pei, D., Sandlund, J. T., Campana, D., Ribeiro, R. C., Razzouk, B. I., Rubnitz, J. E., Howard, S. C., Hijiya, N., Jeha, S., Cheng, C., Downing, J. R., Evans, W. E., Relling, M. V., Hudson, M. (2005). Risk of Adverse Events After Completion of Therapy for Childhood Acute Lymphoblastic Leukemia. JCO 23: 7936-7941 [Abstract] [Full Text]  
• Panzer-Grumayer, E. R., Cazzaniga, G., van der Velden, V. H.J., del Giudice, L., Peham, M., Mann, G., Eckert, C., Schrauder, A., Germano, G., Harbott, J., Basso, G., Biondi, A., van Dongen, J. J.M., Gadner, H., Haas, O. A. (2005). Immunogenotype Changes Prevail in Relapses of Young Children with TEL-AML1-Positive Acute Lymphoblastic Leukemia and Derive Mainly from Clonal Selection. Clin. Cancer Res. 11: 7720-7727 [Abstract] [Full Text]  
• Chiaretti, S., Li, X., Gentleman, R., Vitale, A., Wang, K. S., Mandelli, F., Foa, R., Ritz, J. (2005). Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation. Clin. Cancer Res. 11: 7209-7219 [Abstract] [Full Text]  
• Reddick, W. E., Glass, J. O., Helton, K. J., Langston, J. W., Li, C.-S., Pui, C.-H. (2005). A Quantitative MR Imaging Assessment of Leukoencephalopathy in Children Treated for Acute Lymphoblastic Leukemia without Irradiation. Am. J. Neuroradiol. 26: 2371-2377 [Abstract] [Full Text]  
• Haferlach, T., Kohlmann, A., Schnittger, S., Dugas, M., Hiddemann, W., Kern, W., Schoch, C. (2005). Global approach to the diagnosis of leukemia using gene expression profiling. Blood 106: 1189-1198 [Abstract] [Full Text]  
• Soulier, J., Clappier, E., Cayuela, J.-M., Regnault, A., Garcia-Peydro, M., Dombret, H., Baruchel, A., Toribio, M.-L., Sigaux, F. (2005). HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 106: 274-286 [Abstract] [Full Text]  
• Rocha, J. C. C., Cheng, C., Liu, W., Kishi, S., Das, S., Cook, E. H., Sandlund, J. T., Rubnitz, J., Ribeiro, R., Campana, D., Pui, C.-H., Evans, W. E., Relling, M. V. (2005). Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 105: 4752-4758 [Abstract] [Full Text]  
• De Keersmaecker, K., Graux, C., Odero, M. D., Mentens, N., Somers, R., Maertens, J., Wlodarska, I., Vandenberghe, P., Hagemeijer, A., Marynen, P., Cools, J. (2005). Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). Blood 105: 4849-4852 [Abstract] [Full Text]  
• Reddick, W. E., Glass, J. O., Helton, K. J., Langston, J. W., Xiong, X., Wu, S., Pui, C.-H. (2005). Prevalence of Leukoencephalopathy in Children Treated for Acute Lymphoblastic Leukemia with High-Dose Methotrexate. Am. J. Neuroradiol. 26: 1263-1269 [Abstract] [Full Text]  
• DeAngelo, D. J. (2005). The Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia. ASH Education Book 2005: 123-130 [Abstract] [Full Text]  
• Armstrong, S. A. (2004). Leukemia gene expression: MLL rearrangements in AML and ALL. Blood 104: 3423-3424 [Full Text]  
• Pui, C.-H., Sandlund, J. T., Pei, D., Campana, D., Rivera, G. K., Ribeiro, R. C., Rubnitz, J. E., Razzouk, B. I., Howard, S. C., Hudson, M. M., Cheng, C., Kun, L. E., Raimondi, S. C., Behm, F. G., Downing, J. R., Relling, M. V., Evans, W. E. (2004). Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 104: 2690-2696 [Abstract] [Full Text]  
• Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P. IV, Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., Aster, J. C. (2004). Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia. Science 306: 269-271 [Abstract] [Full Text]  
• Fasth, A., Wahlstrom, J. (2004). Preimplantation Testing to Produce an HLA-Matched Donor Infant. JAMA 292: 803-803 [Full Text]  
• Hocking, B., Pui, C.-H., Relling, M. V., Downing, J. R. (2004). Magnetic Fields and Leukemia. NEJM 351: 102-102 [Full Text]  
• Huang, M. S., Hasserjian, R. P. (2004). Case 19-2004 - A 12-Year-Old Boy with Fatigue and Eosinophilia. NEJM 350: 2604-2612 [Full Text]  
• Pui, C.-H., Schrappe, M., Ribeiro, R. C., Niemeyer, C. M. (2004). Childhood and Adolescent Lymphoid and Myeloid Leukemia. ASH Education Book 2004: 118-145 [Abstract] [Full Text]